Assessing the resistance to calcification of polyurethane membranes used in the manufacture of ventricles for a totally implantable artificial heart.

Ventricles made from segmented polyurethane membranes and used in the fabrication of a totally implantable artificial heart are known to undergo biomaterial-associated calcification. As there is no effective method currently available to prevent such biomaterials from calcifying, a practical solution is to use only materials with a relatively high resistance to calcification, to extend ventricular durability and ensure a longer functional life for the manufactured device. In the present study, an in vitro calcification protocol was used to determine the relative resistance to calcification of six different polyurethanes, namely, Carbothane PC3570A, Chronoflex AR, Corethane 80A, Corethane 55D, Tecoflex EG80A, and Tecothane TT1074A. The results demonstrated that all six polyurethanes did become calcified during the 60-day incubation period in the calcification solution. The degree of calcification was found to be associated with the surface chemistry of the particular polyurethane, with the Tecothane TT1074A exhibiting the highest level. The Corethane 80A and 55D polymers showed a relatively low propensity to calcify. These two membranes can, therefore, be considered as the most appropriate materials for the fabrication of ventricles for a totally implantable artificial heart. In addition, since the calcification occurred primarily at the surface of the membranes, without affecting the bulk microphase structure, the issue of modifying the surface chemistry to reduce the incidence of calcification is discussed.

[1]  R. Guidoin,et al.  Totally implantable artificial hearts and left ventricular assist devices: selecting impermeable polycarbonate urethane to manufacture ventricles. , 1999, Journal of biomedical materials research.

[2]  H Harasaki,et al.  Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. , 1988, Journal of biomedical materials research.

[3]  V. Poirier,et al.  SELECTION OF MATERIALS FOR VENTRICULAR ASSIST PUMP DEVELOPMENT AND FABRICATION , 1977, Transactions - American Society for Artificial Internal Organs.

[4]  J. Dillon,et al.  Degradation of five polyurethane gastric bubbles following in vivo use: SEC, ATR-IR and DSC studies. , 1992, Biomaterials.

[5]  H. Harasaki,et al.  Calcification in blood pumps. , 1979, Transactions - American Society for Artificial Internal Organs.

[6]  I. Rehman,et al.  Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy , 1997, Journal of materials science. Materials in medicine.

[7]  James M. Anderson,et al.  Polyurethane Elastomer Biostability , 1995, Journal of biomaterials applications.

[8]  Bruck Sd Calcification of materials in blood contacting implants. , 1985 .

[9]  G. Rosenberg,et al.  Calcification inside artificial hearts: inhibition by warfarin-sodium. , 1980, Science.

[10]  S. Cooper,et al.  Differential scanning calorimetry analysis of morphological changes in segmented elastomers , 1980 .

[11]  R. J. Thoma Poly(ether) Urethane Reactivity with Metal-Ion in Calcification and Environmental Stress Cracking , 1986, Journal of biomaterials applications.

[12]  J M Anderson,et al.  In vivo biocompatibility and biostability of modified polyurethanes. , 1997, Journal of biomedical materials research.

[13]  H. Willis Infrared spectroscopic atlas of polyurethanes , 1990 .

[14]  Y Missirlis,et al.  Model experimental system for investigation of heart valve calcification in vitro. , 1997, Journal of biomedical materials research.

[15]  W. Pierce Polymers in Biomedical Devices: Materials for Artificial Heart and Circulatory Assist Devices , 1975 .

[16]  S. Kim,et al.  Novel anti-calcification treatment of biological tissues by grafting of sulphonated poly(ethylene oxide). , 1997, Biomaterials.

[17]  T. Mackay,et al.  Calcification Modelling in Artificial Heart Valves , 1992, The International journal of artificial organs.

[18]  L Pinchuk,et al.  A review of the biostability and carcinogenicity of polyurethanes in medicine and the new generation of 'biostable' polyurethanes. , 1994, Journal of biomaterials science. Polymer edition.

[19]  R. Guidoin,et al.  Morphological, physical and chemical evaluation of the Vascugraft arterial prosthesis: comparison of a novel polyurethane device with other microporous structures. , 1994, Biomaterials.

[20]  I. Wickelgren Synapse-Making Molecules Revealed , 1996, Science.

[21]  J. A. Gadsden Infrared Spectra of Minerals and Related Inorganic Compounds , 1975 .

[22]  D. Briggs,et al.  Primary and secondary oxygen-induced C1s binding energy shifts in X-ray photoelectron spectroscopy of polymers , 1992 .

[23]  G. Golomb,et al.  Development of a new in vitro model for studying implantable polyurethane calcification. , 1991, Biomaterials.

[24]  G. Wilkes,et al.  Structure-property behaviour of segmented polyether-MDI-butanediol based urethanes: effect of composition ratio , 1982 .

[25]  A. M. Reed,et al.  A Solution Grade Biostable Polyurethane Elastomer: ChronoFlex® AR , 1994, Journal of biomaterials applications.